Skip to main content
Log in

Supercritical fluid micronization of risperidone pharmaceutical substance

  • Published:
Russian Journal of Physical Chemistry B Aims and scope Submit manuscript

Abstract

A comparative study of the supercritical fluid micronization of risperidone pharmaceutical substance with an initial particle size of 50 to 100 μm by the RESS and SAS methods aimed at increasing the bioavailability of risperidone as a drug was performed. Both methods makes it possible to prepare risperidone particle of various forms, 5–20 μm in size. However, the SAS method is preferable, because in contrast to RESS, it does not cause contamination of risperidone with organic solvents used in both processes or any other impurities and also makes it possible to vary the shape and size of particles. It is shown that, during SAS micronization, the polymorphic form of risperidone changes from triclinic to monoclinic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. T. L. Rogers, K. A. Overhoff, P. Shah, P. Santiago, M. J. Yacaman, K. P. Johnston, and R. O. Williams III, Eur. J. Pharm. Biopharm. 55, 161 (2003).

    Article  CAS  Google Scholar 

  2. P. Pathak, M. J. Mezjani, T. Desai, and Y.-P. Sun, J. Am. Chem. Soc. 126, 10842 (2004).

    Article  CAS  Google Scholar 

  3. K. Giry, J. M. Pean, L. Giraud, S. Marsas, H. Rolland, and P. Wuthrich, Int. J. Pharm. 321, 162 (2006).

    Article  CAS  Google Scholar 

  4. Y. H. Kim, C. Sioutas, P. Fine, and K. S. Shing, Powder Technol. 182, 354 (2008).

    Article  CAS  Google Scholar 

  5. D. Hermsdorf, S. Jauer, and R. Signorell, Mol. Phys. 105, 951 (2007).

    Article  CAS  Google Scholar 

  6. M. Bahrami and S. Ranjbarian, J. Supercrit. Fluids 40, 263 (2007).

    Article  CAS  Google Scholar 

  7. E. Reverchon, G. Della Porta, and A. Spada, J. Pharm. Pharmacol. 55, 1465 (2003).

    Article  CAS  Google Scholar 

  8. E. Reverchon, G. Della Porta, A. Spada, and A. Antonacci, J. Pharm. Pharmacol. 56, 1379 (2004).

    Article  CAS  Google Scholar 

  9. T. K. Bastaman, R. Budiman, A. Kumawardhani, A. N. Irmansyah, and R. Salan, Eur. Neuropshychopharmacol. 6(Suppl. 3, Orals), 149 (1996).

    Article  Google Scholar 

  10. D. Kayrak, U. Akman, and S. U. Hortace, J. Supercrit. Fluids 26, 17 (2003).

    Article  CAS  Google Scholar 

  11. I. Karabas, M. G. Orkoula, and C. G. Kontoyannis, Talanta 71, 1382 (2007).

    Article  CAS  Google Scholar 

  12. M. Leigh, T. Reimann, J. Grunkemeyer, B. Schneider, H. Schwebel, and P. van Hoogevest, “A Polymorphism Screen of Risperidone: A comparison of XRPD and Raman Spectroscopy,” AAPS J. 9(S2) (2007).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. N. Bagratashvili.

Additional information

Original Russian Text © V.N. Bagratashvili, A.M. Egorov, L.I. Krotova, A.V. Mironov, V.Ya. Panchenko, O.O. Parenago, V.K. Popov, I.A. Revelsky, P.S. Timashev, S.I. Tsypina, 2011, published in Sverkhkriticheskie Flyuidy: Teoriya i Praktika, 2011, Vol. 6, No. 4, pp. 88–102.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bagratashvili, V.N., Egorov, A.M., Krotova, L.I. et al. Supercritical fluid micronization of risperidone pharmaceutical substance. Russ. J. Phys. Chem. B 6, 804–812 (2012). https://doi.org/10.1134/S1990793112070019

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1990793112070019

Keywords

Navigation